A Note From the United Soybean Association

What’s the Real Scoop on Soy? (Part 3)

While more studies will likely occur in the future for reasons of consistency and conclusiveness, the American Heart Association's January 2006 report on soy's relationship to osteoporosis stated that the "estrogenic effect of soy isoflavones could be to reduce bone loss after menopause [as indicated in] population studies and certain animal models of animal osteoporosis." In some soy studies, bone loss was lessened over a period of 6 to 24 months, and some other studies showed favorable effects on the spine or in "bone mineral content but not bone mineral density."

Moreover, the AHA report said, "the weak estrogenic action of soy isoflavones and other phytoestrogens suggested the possibility that they could lessen the deleterious effects of more potent endogenous estrogens on breast and endometrial cancer." Its basis "came from the low incidence of breast and endometrial cancers in Asian countries where soy products are prevalent in the diet and from certain animal models of breast and endometrial cancer showing benefit of soy isoflavones."

Eat well and be well!

Marlon Wade
Co-Founder
Café Soy, LLC
info@cafesoy.com
http://www.cafesoy.com